JournalScan
| The first 150 words of the full text of this article appear below. |
GENERAL CARDIOLOGY
Should the apolipoprotein B/A1 ratio become the routine lipid measurement for cardiovascular risk stratification? From a pathophysiological point of view, the Apo B/A1 ratio is more reflective of endothelial dysfunction and atherosclerosis development than the level of low-density lipoprotein (LDL) cholesterol. However, results from several small studies (200–300 events) have been conflicting—while some showed a superiority of Apo B/A1 over conventional lipid measurements, others, including a report from the Framingham heart study, did not.
Data from the INTERHEART study were used to measure cholesterol and apolipoprotein ratios for 9345 cases of myocardial infarction and 12 120 controls. The Apo B/A1 ratio had the highest population-attributable risk (54%), compared with the LDL/high-density lipoprotein (HDL) cholesterol ratio which was 37%, and total cholesterol/HDL ratio which was 32%, significantly lower than the Apo B/A1 ratio (p<0.0001). These results were consistent across all ethnic groups, both sexes and all ages.
A trend appears to
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
